Cardiac Myofibroblast‐Derived Small Extracellular Vesicles Moderate Fibrotic Responses via piRNA‐62788/PIWIL2‐Mediated SRF Silencing
Open Access
- 28 November 2025
- journal article
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 14 (12) , e70204
Abstract
During fibrogenesis, certain negative feedback loops are elicited to restrain persistent and hyperactive fibrotic responses. Activated fibroblasts have been found to acquire anti‐fibrotic phenotypes. However, the specific inhibitory modulators remain largely enigmatic. Thus, the present study aimed to examine the intrinsic autoregulatory mechanisms of fibroblasts. Here, we demonstrated that angiotensin II (AngII)‐primed cardiac myofibroblast moderated subsequent profibrotic activation. More importantly, this suppressive action was dependent on small extracellular vesicles (sEVs). Strikingly, small RNA sequencing identified an abundant presence of Piwi‐interacting RNAs (piRNAs) in sEVs. In cultured primary cardiac fibroblasts, piRNA‐62788 was induced by AngII receptor type 2 (AT 2 R) stimulation and encapsulated into sEVs. Furthermore, fibrogenic responses were attenuated by piRNA‐62788 overexpression, whereas aggravated by piRNA‐62788 knockdown. In a mouse model of transverse aortic constriction, either piRNA‐62788 agomir or circulating sEVs of patients with heart failure (HF) mitigated adverse cardiac remodelling, while piRNA‐62788 inhibitor‐containing sEVs accentuated myocardial fibrosis. Mechanistically, piRNA‐62788 formed a functional complex with PIWI‐like protein 2 (PIWIL2) and bound to the 3’ untranslated region (UTR) region of serum response factor ( Srf ) mRNA transcripts, leading to inhibition of the SRF signalling. Additionally, plasma sEV‐derived piRNA‐62788 was significantly upregulated in HF patients and negatively correlated with left ventricular ejection fraction. Collectively, we uncovered a protective negative feedback circuit controlled by AngII/AT 2 R/sEVs axis. Understanding this endogenous anti‐fibrotic pathway may hold therapeutic promise in HF.Keywords
Funding Information
- National Natural Science Foundation of China (82070403)
- National Natural Science Foundation of China (82270374)
This publication has 58 references indexed in Scilit:
- A Broadly Conserved Pathway Generates 3′UTR-Directed Primary piRNAsCurrent Biology, 2009
- Critical Role of Serum Response Factor in Pulmonary Myofibroblast Differentiation Induced by TGF-βAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblastsNature, 2008
- Differential Behaviors of Atrial Versus Ventricular FibroblastsCirculation, 2008
- Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological FluidsCurrent Protocols in Cell Biology, 2006
- The Role of MicroRNA-1 and MicroRNA-133 in Skeletal Muscle Proliferation and Differentiation.Nature Genetics, 2005
- Double-stranded RNA-mediated silencing of genomic tandem repeats and transposable elements in the D. melanogaster germlineCurrent Biology, 2001
- Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factorAmerican Journal of Physiology-Heart and Circulatory Physiology, 2001
- An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growthCardiovascular Research, 1999
- Characterization of angiotensin II receptor subtypes in rat liver.Journal of Biological Chemistry, 1984